Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Biochim Biophys Acta. 2017 Mar 29;1863(10 Pt A):2414–2435. doi: 10.1016/j.bbadis.2017.03.020

Figure 3.

Figure 3

Small-molecule melanocortin scaffolds derived from the Merck compound THIQ. Scaffolds are grouped by company disclosing the structures: Merck (green), Neurocrine Biosciences, Inc. (red), or Pfizer (blue). In the center, THIQ, MB243, and MK0493 are select Merck compounds disclosed before 2007, the His-DPhe-Arg-Trp hypothesized melanocortin pharmacophore, and an illustrative spiroinanyl piperidine core structure.